Novosound which is based in Scotland and has designed and developed first ultrasonic blood pressure monitor has announced the funding of £2 million from Par Equity and other prominent investors like University of the West of Scotland, Scottish Enterprise and Kelvin Capital.
Novosound has said that this funding will help the company to commercialize its innovative ultrasonic blood pressure monitor which does not require cuffs like present ultrasonic machines and can be embedded in to smart watches, smart rings, etc. and since Scotland it at the forefront of ultrasound innovation, the company is proud to disrupt the field positively with high accuracy.
Dave Hughes is the Chief Executive Officer at Novosound and he has founded this company around 5 years ago with a vision of having Integrated Ultrasound System everywhere, from hospital to homes so that the humankind gets full benefit of this technology. Previously. he has worked at the University of The West of Scotland as the Research Theme Leader in Ultrasound Imaging.
Novosound has already created wireless wearable ultrasound machines which are commercialized and is being used for the digital health monitoring and other medical applications by professionals from a long time. As we know, around half a billion people are currently suffering from Cardiovascular diseases globally and only in the year 2021, we have seen around 20 million deaths as per the World Heart Federation. With this innovation and commercialization, company is planning to make a huge impact on the society.
Leave a Reply